Cue Health Inc.

General Information
Cue Health sells COVID-19 tests for home use and other tests to diagnose other diseases.
We are a health technology company, and our mission is to enable personalized, proactive and informed healthcare that empowers people to live their healthiest lives. Digital transformation has revolutionized nearly every industry except healthcare to create new, consumer-first experiences that are both personalized and empowering. We seek to usher in a new era in healthcare, what we call Healthcare 2.0, to transform how acute and chronic conditions are diagnosed and managed.
We believe the current healthcare system is challenged. Care delivery can often be uncontextualized and disconnected in an increasingly personalized and connected world. The vast majority of healthcare delivery still relies on in-person encounters at centralized locations while consumers and caregivers may often be forced to make important health decisions without complete or real-time information.
(Note: Cue Health priced its IPO on Sept. 23, 2021, at $16 – the mid-point of its $15-to-$17 range – and priced 12.5 million shares, the same number of shares in the prospectus, to raise $200 million.)
Industry: COVID-19 Home Tests & Digital Health Platform
Employees: 1254
Founded: 2010
Contact Information
Address 4980 Carroll Canyon Rd. Suite 100 San Diego, CA 92121
Phone Number (858) 412-8151
Web Address
View Prospectus: Cue Health Inc.
Financial Information
Market Cap $2300.0mil
Revenues $219.85 mil (last 12 months)
Net Income $4.77 mil (last 12 months)
IPO Profile
Symbol HLTH
Exchange NASDAQ
Shares (millions): 12.5
Price range $16.00 - $16.00
Est. $ Volume $200.0 mil
Manager / Joint Managers Goldman Sachs/ Morgan Stanley/ Cowen and Company
CO-Managers BTIG
Expected To Trade: 9/24/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change